Clinical trial

Mesenchymal Stem Cells in Early Rheumatoid Arthritis

NCT03186417

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2017-12-15

PhasePHASE1

Study timeline

Study start (actual)2017-12-15Date precision: day

Registry last updated2023-06-23

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Rheumatoid Arthritisunresolved

Interventions

2 million hMSC/kgBIOLOGICAL

4 million hMSC/kgBIOLOGICAL

6 million hMSC/kgBIOLOGICAL

placeboBIOLOGICAL

Sponsors & collaborators

MetroHealth Medical Centerlead sponsor

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)collaborator

Mapped research locations

ClevelandOhio, United States2

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03186417 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.